Kenneth Blum on 2016

This AI Prediction was made by Kenneth Blum in 2016.

Predicted time for AGI / HLMI / transformative AI:

(Hover for explanation)Types of advanced artificial intelligence: AGI (AI that can perform many tasks at a human-level), HLMI (more advanced AI that surpasses human intelligence in specific areas), and Transformative AI (AI that could significantly impact society and the world)

The truth is that we have no idea when this could happen, but it is unlikely to be any time soon. In fact, we have little understanding of what comprises human intelligence—certainly at the level of underlying mechanism, but even at the level of scientific description

Opinion about the Intelligence Explosion from Kenneth Blum:

Not provided

Flycer’s explanation for better understanding:

It is uncertain when human-level artificial intelligence will be achieved. Our understanding of human intelligence is limited, both in terms of underlying mechanisms and scientific description. It is unlikely that human-level artificial intelligence will be achieved in the near future.

The future of humanity with AGI / HLMI / transformative AI:

A large program to develop the science of intelligence would be the most important way for the federal government of the United States to provide public benefit from the field of artificial intelligence and lead the way towards what may become the biggest revolution in the history of civilization.

Flycer’s Secondary Explanation:

The federal government of the United States should develop a large program to advance the science of intelligence. This would be the most important way to provide public benefit from artificial intelligence and lead the way towards a potential revolution in civilization. The program would be crucial for the future of AI.

About:

Kenneth Blum is a renowned researcher and scientist who has made significant contributions to the field of addiction and genetics. He is widely recognized for his pioneering work in identifying the genetic basis of addiction and developing innovative treatments for substance abuse disorders.Blum received his Ph.D. in neuropharmacology from New York Medical College and went on to complete postdoctoral training at the National Institute of Mental Health. He has held academic positions at several prestigious institutions, including the University of Texas Health Science Center and the University of Florida College of Medicine.Blum’s research has focused on the role of genetics in addiction and the development of personalized treatment approaches. He is the co-founder of the field of “nutrigenomics,” which explores the interaction between nutrition and genetics in the prevention and treatment of addiction.Blum has published over 500 scientific articles and has been awarded numerous honors for his contributions to the field of addiction research. He is a fellow of the American College of Neuropsychopharmacology and a member of the National Academy of Inventors.In addition to his research, Blum is a sought-after speaker and has presented at conferences and events around the world. He is also the founder of several companies focused on developing innovative treatments for addiction and related disorders.Overall, Kenneth Blum’s groundbreaking research and innovative approaches to addiction treatment have had a significant impact on the field of addiction and genetics, and his work continues to inspire and inform researchers and clinicians around the world.